Company Directory

Macquarie University Medical School’s Faculty of Medicine, Health and Human Sciences conducts research spanning the […]

Malvern Panalytical's scientific measurement instruments are used by the pharmaceutical industry to confirm the identity, activity, molecular conformation, morphological properties, solid form and stability of APIs and excipients. There are many applications in drug delivery.

MannKind Corporation focuses on the development and commercialisation of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. MannKind is currently commercialising its US FDA-approved Afrezza® (insulin human) Inhalation Powder.

Marchesini Group is a manufacturer of automatic pharmaceutical and cosmetic packaging machines, based in Italy's Packaging Valley. The company's pharmaceutical solutions cover aseptic, liquid, inspection, solid, powder, cream, labelling and serialisation, secondary packaging, and end of line.

Matchstick is speciality consultancy focused on pre-concept and concept stage development of combination products including medical devices, patient support and engagement programmes, training and lifecycle strategies. The company has a strong focus on drug delivery devices.

Mati Therapeutics is developing its Punctal Plug Delivery System, a minimally invasive technology that can be used to introduce a variety of therapeutic agents to the eye through controlled, sustained release to the tear film. Initial target indications are glaucoma and ocular hypertension.

maxon motor provides high-precision motors across a range of industries. Its motors can be used to drive various drug delivery systems, including insulin pumps. The company is working on the next generation of drive solutions for drug delivery, including for syringes and needle-free solutions.

MC10 developed wearable products using ultra-thin, flexible body-worn sensors with advanced analytics to gain health insights from physiological data, giving potential in data monitoring and gathering with connected delivery systems. It was acquired by Medidata in 2020.
This company is inactive

Medical Device Usability (MDU), a consultancy specialising in usability and human factors for medical devices, performed formative and summative human factors studies for global pharma, medical device and diagnostics clients. MDU was acquired by UL in 2018.
This company is inactive

Medical Engineering Technologies specialises in medical device and packaging testing, including drug delivery devices such as autoinjectors. MET is equipped for performance testing, chemical analyses and sterile barrier verification, and with accreditation to ISO 17025.

Medicom Innovation Partner was acquired by Phillips-Medisize in 2016, and fully integrated. It developed connectivity services including for injectable, inhalable and oral drugs and provided development and pilot/low-volume production services focused on rare diseases and orphan drugs.
This company is inactive

Medicsen is developing SmartPatch, a transdermal delivery system that uses sonophoresis (based on patented, miniaturised ultrasound-generation technology) to create a transitory disorganisation of the stratum corneum, increasing the skin's permeability, including to macromolecules.

MedPharm operates a hybrid business model, with a CRO business focusing on pharmaceutical development and a patent portfolio of topical and transdermal delivery systems. Its expertise is in topical (skin, nail, eye, nose, lungs and other mucosal membranes) and transdermal products.

Medspray develops spray nozzles for user-friendly consumer health (nasal, ophthalmic, topical), pharma and personal care products, making propellants redundant and increasing user friendliness. Its nozzles can be used for various purposes, especially where a slow-moving, soft spray is required.

Merck Group is a global science and technology company. In the healthcare sector, the company has a broad range of interests, including specialty pharma and biopharma research and development, and a major software design centre for connected drug delivery devices.

Merxin designs and supplies generic and customised inhaler device platforms, including multidose dry powder inhalers, capsule dry powder inhalers, soft mist inhalers, no heat no PG vaping devices and devices tailored to cannabinoid delivery to the lungs and nasal cavities.

Metric Contract Services, founded in 1994, now a division of Mayne Pharma, is an oral solid dosage form CDMO providing formulation development, analytical testing and commercial manufacturing services to support drug development from concept to global commercialisation.

Mexichem Fluor, a division of the multinational chemical company, Mexichem, is one of the largest developers, manufacturers and suppliers of fluorochemicals in the world. Its hydrofluoroalkanes (HFAs) are used as propellants in 80% of all metered-dose inhalers.

Micro Engineering Solutions is a micro device product development and design service provider to medical and drug delivery device OEMs. The company offers vertically integrated micro fabrication, clinical knowledge, and scalable design and risk mitigation plans from product concept to high-volume.

MG2 supplies automatic machines for the pharmaceutical, cosmetic and food industries, including containment solutions, capsule fillers for oral dosage forms and inhalation applications, and primary and secondary packaging solutions, all supported by a full service offering.

Microdermics is developing and commercialising a novel hollow microneedle platform, which has applications both in bio-sensing and intradermal drug delivery. The technology is intended to provide minimally invasive precise and easy access to the skin.

MicroMED is a MEMS microchip design house specialising in the development of microinjection devices targeting unmet needs in the most challenging drug delivery applications. It has established a proprietary high-precision MEMS drug delivery engine system.

Micromeritics supplies characterisation systems for particles, powders and porous materials. Focusing on physical properties, chemical activity and flow properties, its portfolio includes pycnometry, adsorption, dynamic chemisorption, intrusion porosimetry, powder rheology, and particle size.

Micron Biomedical is developing a proprietary applicator-free dissolving microneedle patch technology to enable products with enhanced therapeutic efficacy (including vaccines with enhanced immunogenicity), simplified logistics and improved patient compliance.

Midas Pharma is a mid-sized pharmaceutical company that offers products and services across the full industry value chain, using a virtual model that provides expertise and project management around pharmaceutical supply chains, while connecting partner companies.

Midatech Pharma develops and commercialises products in oncology and other therapeutic areas, based on its two platform technologies - a drug-conjugate targeting technology and a micro-encapsulation technology for prolonged release - that can be used alone or in combination.

Mikron Automation provides scalable and customised assembly systems across numerous industry sectors. Within medtech and pharma, it serves both the parenteral and inhalation delivery device categories, from proof of principle through clinical pilot lines to fully automated solutions.

MGC is a major chemical products manufacturer operating across a wide range of industries. In the field of drug delivery, the company's Advanced Business Development Division has developed OXYCAPT™ Vial & Syringe from a novel polymer, as an alternative to glass primary packaging.

Monash University is a major global, research-intensive university. Research (including partnerships with industry) on drug delivery-related topics are conducted in the Department of Mechanical and Aerospace Engineering as well as at Faculty of Pharmaceutical Sciences.